Hui Xue Selected Research

Capsules (Microcapsules)

4/2016	Subrenal capsule grafting technology in human cancer modeling and translational cancer research.
8/2015	Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies.
3/2014	Enhanced anticancer activity of a combination of docetaxel and Aneustat (OMN54) in a patient-derived, advanced prostate cancer tissue xenograft model.
3/2012	Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target.
1/2011	Identification of novel therapeutic targets in microdissected clear cell ovarian cancers.
8/2008	Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy.
9/2007	Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: identification of apoptotic genes as targets for demethylation.
7/2006	Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: potential models for studying tumor progression-related changes.
11/2005	An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line.
1/2005	Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hui Xue Research Topics

Disease

69	Neoplasms (Cancer) 05/2022 - 01/2005
40	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 11/2005
21	Ischemia 03/2021 - 12/2003
20	Reperfusion Injury 03/2021 - 02/2002
15	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2007
13	Inflammation (Inflammations) 01/2022 - 07/2006
9	Stomach Neoplasms (Stomach Cancer) 09/2022 - 02/2009
9	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 07/2011
9	Adenocarcinoma 01/2020 - 07/2006
8	Hypoxia (Hypoxemia) 11/2022 - 05/2010
8	Infections 01/2021 - 07/2005
8	Sepsis (Septicemia) 04/2015 - 11/2006
8	Wounds and Injuries (Trauma) 04/2013 - 03/2006
7	Lung Neoplasms (Lung Cancer) 05/2022 - 07/2006
7	Heart Failure 01/2022 - 05/2009
7	Infarction (Infarctions) 01/2021 - 12/2011
7	Breast Neoplasms (Breast Cancer) 01/2021 - 04/2007
7	Myocardial Ischemia (Ischemic Heart Diseases) 11/2015 - 05/2009
6	Hemorrhage 01/2022 - 11/2011
6	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 01/2005
5	Ascites 01/2022 - 09/2010
5	Body Weight (Weight, Body) 04/2019 - 01/2002
5	Carcinoma (Carcinomatosis) 12/2018 - 07/2006
5	Brain Ischemia (Cerebral Ischemia) 04/2016 - 06/2011
4	Cicatrix (Scar) 01/2022 - 04/2004
4	Spinal Cord Injuries (Spinal Cord Injury) 01/2021 - 01/2013
4	Fibrosis (Cirrhosis) 01/2021 - 09/2012
4	Brain Diseases (Brain Disorder) 01/2021 - 11/2014
4	Carcinogenesis 12/2020 - 03/2009
4	Myocardial Infarction 01/2020 - 07/2005
3	Disease Progression 01/2022 - 12/2013
3	Carbon Monoxide Poisoning (Poisoning, Carbon Monoxide) 01/2021 - 01/2017
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 09/2005
3	Colorectal Neoplasms (Colorectal Cancer) 12/2019 - 02/2009
3	Hyperlipidemias (Hyperlipidemia) 01/2019 - 01/2002
3	Portal Hypertension 01/2019 - 11/2011
3	Poisoning 03/2017 - 11/2014
3	Necrosis 04/2016 - 09/2014
3	Brain Injuries (Brain Injury) 08/2014 - 04/2012
3	Ovarian Epithelial Carcinoma 04/2014 - 01/2011
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2022 - 01/2022
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

31	LeptinIBA 04/2016 - 01/2002
26	Proteins (Proteins, Gene)FDA Link 11/2022 - 02/2002
14	Pharmaceutical PreparationsIBA 01/2020 - 02/2011
13	AndrogensIBA 01/2022 - 02/2007
13	Biological ProductsIBA 01/2022 - 01/2013
12	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 02/2007
11	Messenger RNA (mRNA)IBA 11/2022 - 02/2002
11	CytokinesIBA 08/2019 - 12/2003
11	salicylhydroxamic acid (SHAM)IBA 04/2016 - 02/2005
10	Capsules (Microcapsules)IBA 04/2016 - 01/2005
7	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2011
7	GadoliniumIBA 11/2021 - 09/2012
7	Hormones (Hormone)IBA 01/2021 - 03/2006
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2006
7	EnzymesIBA 01/2021 - 03/2006
7	Long Noncoding RNAIBA 01/2021 - 02/2014
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2009
6	Adenosine (Adenocard)FDA LinkGeneric 01/2021 - 12/2012
5	Lactic Acid (Lactate)FDA LinkGeneric 11/2020 - 04/2013
4	Carbon MonoxideIBA 01/2021 - 11/2014
4	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2021 - 03/2008
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 04/2013
4	C-Reactive ProteinIBA 11/2010 - 09/2005
4	Fatty Acid-Binding ProteinsIBA 08/2009 - 02/2007
3	AntigensIBA 01/2022 - 01/2020
3	Small Interfering RNA (siRNA)IBA 03/2021 - 10/2013
3	Sincalide FDA Link 01/2021 - 01/2020
3	CateninsIBA 10/2020 - 01/2014
3	Saline SolutionIBA 02/2020 - 10/2007
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2019 - 04/2012
3	ChromatinIBA 01/2019 - 09/2014
3	Superoxide DismutaseIBA 11/2015 - 02/2007
3	Neuroprotective AgentsIBA 01/2015 - 12/2011
3	SurvivinIBA 09/2014 - 10/2013
3	Caspase 3 (Caspase-3)IBA 07/2011 - 05/2010
3	Interleukin-16 (Interleukin 16)IBA 11/2009 - 02/2009
3	Alanine Transaminase (SGPT)IBA 11/2009 - 08/2007
3	Fatty Acid Binding Protein 3IBA 08/2009 - 04/2007
3	Peroxidase (Myeloperoxidase)IBA 08/2009 - 02/2007
3	Indomethacin (Indometacin)FDA LinkGeneric 08/2007 - 11/2006
3	OrexinsIBA 07/2006 - 01/2004
2	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2020
2	Dextran SulfateIBA 01/2022 - 04/2019
2	Cell-Free Nucleic AcidsIBA 01/2022 - 12/2020

Therapy/Procedure

46	Therapeutics 09/2022 - 07/2006
15	Castration 01/2022 - 02/2014
10	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2022 - 11/2011
9	Transjugular Intrahepatic Portasystemic Shunt 01/2022 - 11/2011
7	Drug Therapy (Chemotherapy) 01/2021 - 08/2008
5	Radiotherapy 07/2021 - 01/2017
5	Renal Dialysis (Hemodialysis) 01/2016 - 12/2010
5	Transplantation 11/2015 - 11/2005
3	Immunotherapy 01/2022 - 01/2021
3	Intraperitoneal Injections 12/2019 - 06/2011
3	Ligation 05/2010 - 11/2006
2	Aftercare (After-Treatment) 02/2022 - 11/2021
2	Hepatectomy 01/2022 - 01/2020
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 01/2021